Cargando…
Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells
Autoimmune hepatitis (AIH) is an immune-mediated inflammatory liver disease of uncertain cause. Accumulating evidence shows that gut microbiota and intestinal barrier play significant roles in AIH thus the gut–liver axis has important clinical significance as a potential therapeutic target. In the p...
Autores principales: | Zhang, Hongxia, Liu, Man, Liu, Xin, Zhong, Weilong, Li, Yanni, Ran, Ying, Guo, Liping, Chen, Xu, Zhao, Jingwen, Wang, Bangmao, Zhou, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573389/ https://www.ncbi.nlm.nih.gov/pubmed/33123141 http://dx.doi.org/10.3389/fimmu.2020.569104 |
Ejemplares similares
-
Bifidobacterium animalis ssp. lactis 420 Protects against Indomethacin-Induced Gastric Permeability in Rats
por: Lyra, Anna, et al.
Publicado: (2012) -
Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research
por: Uusitupa, Henna-Maria, et al.
Publicado: (2020) -
Polydextrose with and without Bifidobacterium animalis ssp. lactis 420 drives the prevalence of Akkermansia and improves liver health in a multi-compartmental obesogenic mice study
por: Yde, Christian Clement, et al.
Publicado: (2021) -
Effects of Bifidobacterium animalis ssp. lactis 420 on gastrointestinal inflammation induced by a nonsteroidal anti‐inflammatory drug: A randomized, placebo‐controlled, double‐blind clinical trial
por: Mäkelä, Sanna M., et al.
Publicado: (2021) -
Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice
por: Martín, Rebeca, et al.
Publicado: (2016)